ArticleMedicine2026
Higher light at night exposure is associated with increased risk of diabetes mellitus: A cross-sectional study of the NHANES database.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While evidence links light at night (LAN) to metabolic disturbances, large-scale, population-based studies of objectively-measured LAN exposure remain limited. This study investigates the association between LAN and the risk of diabetes mellitus (DM) among US adults using data from the National Health and Nutrition Examination Survey. Cross-sectional data from the 2011 to 2014 National Health and Nutrition Examination Survey cycles were analyzed, focusing on participants with complete data on both LAN and DM. Participants were stratified by LAN level. Multivariable logistic regression analyses were employed to examine the association between LAN and DM. Multivariable linear regression analyses assessed relationships between LAN and diabetes risk markers, including hemoglobin A1c (HbA1c), fasting blood glucose, fasting serum insulin, and Homeostasis Model Assessment of Insulin Resistance (HOMA-IR). Subgroup and sensitivity analyses with multiple imputation tested robustness. A total of 4498 participants were enrolled. The prevalence of diabetes was higher in the high-LAN exposure group compared to the no-LAN group (21.01% vs 14.48%). Consistent with this, in the fully adjusted model, high-LAN exposure was independently associated with a significantly increased risk of DM (odds ratio [OR] = 1.39, 95% confidence interval [CI]: 1.00-1.92). High-LAN exposure was linked to elevated HbA1c and fasting blood glucose in initial models. However, these associations weakened and became nonsignificant after full adjustment for covariates. No significant associations were observed for fasting serum insulin or HOMA-IR. Subgroup analyses showed the association between LAN and DM was more pronounced in middle-aged adults (40-64 years), individuals with obesity, and those with dyslipidemia or hypertension. However, no significant effect modification was found across subgroups (all P for interaction > .05). Sensitivity analyses confirmed the robustness of these findings. This study uses objective actigraphy-based LAN measurement and shows its independent association with DM, especially in metabolically susceptible subgroups. These findings identify LAN as a modifiable environmental risk factor and support its relevance to DM prevention and public health strategy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.